Date |
Product |
Disease |
Phase |
Company |
Therapeutic area |
2016-08-07
|
dMAb® DNA targeting HIV |
HIV infection |
|
Inovio Pharmaceuticals (USA - PA) |
Infectious diseases |
2016-08-05
|
cariprazine |
major depressive disorder |
3 |
Gedeon Richter (Hungary) Allergan (Ireland) |
CNS diseases - Mental diseases |
2016-08-04
|
ReN001 (CTX cell therapy) |
stroke |
1 |
Reneuron (UK) |
Cerebrovascular diseases |
2016-08-04
|
Grafix® |
complex diabetic foot wounds |
4 |
Osiris Therapeutics (USA - MD) |
Regenerative Medicine |
2016-08-04
|
necuparanib (M402) in combination with Abraxane® (paclitaxel) and gemcitabine |
metastatic pancreatic cancer |
1-2 |
Momenta Pharmaceuticals (USA - MA) |
Cancer - Oncology |
2016-08-03
|
AB-SA01 (phage cocktail targeting Staphylococcus aureus) |
Staphylococcus aureus infections |
1 |
AmpliPhi BioSciences (USA - VA) |
Infectious diseases |
2016-08-03
|
heat stable subunit Ebola vaccine |
Ebola fever |
|
Soligenix (USA - NJ) Hawaii Biotech (USA - HI) University of Hawaii (USA - HI) |
Infectious diseases |
2016-08-02
|
PM1183 (lurbinectedin) in combination with doxorubicin |
small cell lung cancer (SCLC) after the failure of one prior platinum containing line |
3 |
PharmaMar (Spain) |
Cancer - Oncology |
2016-08-01
|
RHB-104 |
relapsing remitting multiple sclerosis (RRMS) |
2 |
Redhill Biopharma (Israel) |
Autoimmune diseases - Neurodegenerative diseases |
2016-07-29
|
pembrolizumab (MK-3475) |
urothelial carcinoma |
3 |
Merck&Co (USA - NJ) |
Cancer - Oncology |
2016-07-29
|
pembrolizumab (MK-3475) and axitinib |
renal cell carcinoma |
3 |
Merck&Co (USA - NJ) |
Cancer - Oncology |
2016-07-29
|
tepotinib |
lung adenocarcinoma stage IIIB/IV |
2 |
Merck KGaA (Germany) |
Cancer - Oncology |
2016-07-28
|
emicizumab (ACE910 - anti-factor IXa x anti-factor X humanized bispecific antibody) |
hemophilia A |
1-2 |
Chugai Pharmaceutical (Japan) |
Rare diseases - Genetic diseases - Hematological diseases |
2016-07-28
|
fimaporfin - disulfonated tetraphenyl chlorin (TPCS2a) (Amphinex™) |
advanced solid tumours |
1 |
PCI Biotech (Norway) |
Cancer - Oncology |
2016-07-28
|
BI 695501 (biosimilar version of Humira® (adalimumab)) |
psoriasis |
3 |
Boehringer Ingelheim (Germany) |
Autoimmune diseases - Dermatological diseases |
2016-07-26
|
ND0701 (apomorphine-base) |
Parkinson's disease |
|
Neuroderm (Israel) |
Neurodegenerative diseases |
2016-07-26
|
synthetic vaccine for the Zika virus GLS-5700 |
Zika virus infection |
1 |
Inovio Pharmaceuticals (USA - PA) GeneOne Life Science (Republic of Korea) |
Infectious diseases |
2016-07-26
|
galeterone |
prostate cancer |
3 |
Tokai Pharmaceuticals (USA - MA) |
Cancer - Oncology |
2016-07-25
|
roxadustat |
anemia associated with chronic kidney disease (CKD) |
3 |
FibroGen (USA - CA) Astellas Pharma (Japan) |
Kidney diseases - Renal diseases |
2016-07-25
|
VLA84 |
Clostridium difficile infection |
2 |
Valneva (France - Austria) |
Infectious diseases |